Ns Partners LTD Bristol Myers Squibb CO Transaction History

Ns Partners LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$44.62 - $49.34 $194,632 - $215,221	-4,362 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $19,211 - $24,912	-394 Reduced 8.28%	4,362 $227,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $19,868 - $22,410	-360 Reduced 7.04%	4,756 $295,000
Q2 2018 Aug 02, 2018	SELL	$50.53 - $62.98 $1.77 Million - $2.21 Million	-35,087 Reduced 87.27%	5,116 $283,000
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $37,989 - $43,733	-634 Reduced 1.55%	40,203 $2.54 Million
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $179 - $196	-3 Reduced 0.01%	40,837 $2.5 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $43,852 - $50,609	-794 Reduced 1.91%	40,840 $2.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	41,634	41,634 $2.32 Million

2,403

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $114B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ns Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Ns Partners LTD with notifications on news.